pentadecanoic acid has been researched along with etc-1002 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adeli, K; Baker, C; Bradshaw, CD; Brant, AF; Cramer, CT; Filippov, S; Hanselman, JC; Houghton, JL; Hurley, TR; Naples, M; Newton, RS; Pinkosky, SL; Spahr, MA; Srivastava, RA | 1 |
1 other study(ies) available for pentadecanoic acid and etc-1002
| Article | Year |
|---|---|
AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; ATP Citrate (pro-S)-Lyase; Biomarkers; Calcium; Carbohydrate Metabolism; Cricetinae; Dicarboxylic Acids; Diet; Dyslipidemias; Energy Metabolism; Enzyme Activation; Enzyme Inhibitors; Fatty Acids; Female; Glucagon; Glucose; Hep G2 Cells; Humans; Lipid Metabolism; Liver; Male; Mice; Molecular Targeted Therapy; Obesity; Protein Serine-Threonine Kinases; Rats; Signal Transduction; Sterols | 2013 |